803
Views
46
CrossRef citations to date
0
Altmetric
Research Article

Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers

, , , &
Pages 497-506 | Received 26 Jun 2013, Accepted 19 Jan 2014, Published online: 06 Mar 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Xin-Cheng Zhong, Ming-Han Shi, Hui-Na Liu, Jie-Jian Chen, Tian-Tian Wang, Meng-Ting Lin, Zhen-Tao Zhang, Yi Zhou, Yi-Ying Lu, Wen-Hong Xu, Jian-Qing Gao, Dong-Hang Xu, Min Han & Yi-Ding Chen. (2021) Mitochondrial targeted doxorubicin derivatives delivered by ROS-responsive nanocarriers to breast tumor for overcoming of multidrug resistance. Pharmaceutical Development and Technology 26:1, pages 21-29.
Read now
Shoshy Mizrahy, Anna Gutkin, Paolo Decuzzi & Dan Peer. (2019) Targeting central nervous system pathologies with nanomedicines. Journal of Drug Targeting 27:5-6, pages 542-554.
Read now
Shannon J. Kelly, Kathleen Halasz, Rudy Smalling & Vijaykumar Sutariya. (2019) Nanodelivery of doxorubicin for age-related macular degeneration. Drug Development and Industrial Pharmacy 45:5, pages 715-723.
Read now
Amir Roointan, Sedigheh Kianpour, Fatemeh Memari, Molood Gandomani, Seyed Mohammad Gheibi Hayat & Soliman Mohammadi-Samani. (2018) Poly(lactic-co-glycolic acid): The most ardent and flexible candidate in biomedicine!. International Journal of Polymeric Materials and Polymeric Biomaterials 67:17, pages 1028-1049.
Read now
Anna Gutkin, Zvi R. Cohen & Dan Peer. (2016) Harnessing nanomedicine for therapeutic intervention in glioblastoma. Expert Opinion on Drug Delivery 13:11, pages 1573-1582.
Read now
Heba F Salem, Sayed M Ahmed, Ashraf E Hassaballah & Mahmoud M Omar. (2015) Targeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo study. Drug Design, Development and Therapy 9, pages 3705-3727.
Read now

Articles from other publishers (40)

Tanmay S. Markandeywar, Raj Kumar Narang, Dilpreet Singh & Vineet Kumar Rai. (2023) Targeted Delivery of Doxorubicin as a Potential Chemotherapeutic Agent. Current Drug Delivery 20:7, pages 904-918.
Crossref
Xiangming Guan. (2023) Glutathione and glutathione disulfide – their biomedical and pharmaceutical applications. Medicinal Chemistry Research.
Crossref
Charan Singh Pawar, N. Rajendra Prasad, Priya Yadav, I.V. Muthu Vijayan Enoch, Varnitha Manikantan, Bindiya Dey & Paran Baruah. (2023) Enhanced delivery of quercetin and doxorubicin using β-cyclodextrin polymer to overcome P-glycoprotein mediated multidrug resistance. International Journal of Pharmaceutics 635, pages 122763.
Crossref
Ranjana Bhandari, Jyoti K Paliwal & Anurag Kuhad. (2023) Enhanced Bioavailability and Higher Uptake of Brain-Targeted Surface Engineered Delivery System of Naringenin developed as a Therapeutic for Autism Spectrum Disorder. Current Drug Delivery 20:2, pages 158-182.
Crossref
Yue Na, Ning Zhang, Xinyu Zhong, Jinlian Gu, Chang Yan, Shun Yin, Xia Lei, Jihui Zhao & Fang Geng. (2023) Polylactic-co-glycolic acid-based nanoparticles modified with peptides and other linkers cross the blood–brain barrier for targeted drug delivery. Nanomedicine 18:2, pages 125-143.
Crossref
Naumih M. Noah & Peter M. Ndangili. 2023. Polymeric Nanosystems. Polymeric Nanosystems 723 759 .
Quan Zhou, Junjun Li, Jiajia Xiang, Shiqun Shao, Zhuxian Zhou, Jianbin Tang & Youqing Shen. (2022) Transcytosis-enabled active extravasation of tumor nanomedicine. Advanced Drug Delivery Reviews 189, pages 114480.
Crossref
Asim Najmi, Shenggang Wang, Yue Huang, Teresa Seefeldt, Yahya Alqahtani & Xiangming Guan. (2022) 2-(2-Cholesteroxyethoxyl)ethyl-3′-S-glutathionylpropionate (COXP) for brain-targeting liposomes. Journal of Drug Delivery Science and Technology 75, pages 103674.
Crossref
Shubham Mule, Pooja Khairnar & Rahul Shukla. (2022) Recent Advances in Nanocrystals Heralding Greater Potential in Brain Delivery. Particle & Particle Systems Characterization 39:9, pages 2200087.
Crossref
Jagan Mohan Dodda, Tomáš Remiš, Sadiku Rotimi & Yi-Cheun Yeh. (2022) Progress in the drug encapsulation of poly(lactic- co -glycolic acid) and folate-decorated poly(ethylene glycol)–poly(lactic- co -glycolic acid) conjugates for selective cancer treatment . Journal of Materials Chemistry B 10:22, pages 4127-4141.
Crossref
Wiam El Kheir, Bernard Marcos, Nick Virgilio, Benoit Paquette, Nathalie Faucheux & Marc-Antoine Lauzon. (2022) Drug Delivery Systems in the Development of Novel Strategies for Glioblastoma Treatment. Pharmaceutics 14:6, pages 1189.
Crossref
Asraa Faris Aldoghachi, Ahmed Faris Aldoghachi, Koen Breyne, King-Hwa Ling & Pike-See Cheah. (2022) Recent Advances in the Therapeutic Strategies of Glioblastoma Multiforme. Neuroscience 491, pages 240-270.
Crossref
Bassam Felipe Mogharbel, Marco André Cardoso, Ana Carolina Irioda, Priscila Elias Ferreira Stricker, Robson Camilotti Slompo, Julia Maurer Appel, Nathalia Barth de Oliveira, Maiara Carolina Perussolo, Claudia Sayuri Saçaki, Nadia Nascimento da Rosa, Dilcele Silva Moreira Dziedzic, Christophe Travelet, Sami Halila, Redouane Borsali & Katherine Athayde Teixeira de Carvalho. (2022) Biodegradable Nanoparticles Loaded with Levodopa and Curcumin for Treatment of Parkinson’s Disease. Molecules 27:9, pages 2811.
Crossref
Mobin A. Siddiqui, Mohammad Asad, Juheb Akhter, Ubedul Hoda, Shweta Rastogi, Indu Arora, Nidhi B. Aggarwal & Mohammed Samim. (2022) Resveratrol-Loaded Glutathione-Coated Collagen Nanoparticles Attenuate Acute Seizures by Inhibiting HMGB1 and TLR-4 in the Hippocampus of Mice. ACS Chemical Neuroscience 13:8, pages 1342-1354.
Crossref
Nahal Shamaeizadeh, Jaleh Varshosaz, Mina Mirian & Mehdi Aliomrani. (2022) Glutathione targeted tragacanthic acid-chitosan as a non-viral vector for brain delivery of miRNA-219a-5P: An in vitro/in vivo study. International Journal of Biological Macromolecules 200, pages 543-556.
Crossref
Pearl Dighe. 2022. Nanocarriers for Drug-Targeting Brain Tumors. Nanocarriers for Drug-Targeting Brain Tumors 205 233 .
Payal H. Patil, Chandrakantsing V. Pardeshi & Sanjay J. Surana. 2022. Polymeric nanoparticles for the treatment of solid tumors. Polymeric nanoparticles for the treatment of solid tumors 329 349 .
Mobin A. Siddiqui, Juheb Akhter, Aarzoo, Dar Junaid Bashir, Saliha Manzoor, Shweta Rastogi, Indu Arora, Nidhi B. Aggarwal & Mohammed Samim. (2021) Resveratrol loaded nanoparticles attenuate cognitive impairment and inflammatory markers in PTZ-induced kindled mice. International Immunopharmacology 101, pages 108287.
Crossref
Firda Juhairiyah & Elizabeth C. M. de Lange. (2021) Understanding Drug Delivery to the Brain Using Liposome-Based Strategies: Studies that Provide Mechanistic Insights Are Essential. The AAPS Journal 23:6.
Crossref
Jisu Song, Chao Lu, Jerzy Leszek & Jin Zhang. (2021) Design and Development of Nanomaterial-Based Drug Carriers to Overcome the Blood–Brain Barrier by Using Different Transport Mechanisms. International Journal of Molecular Sciences 22:18, pages 10118.
Crossref
Tamás Fekete, Mária Mészáros, Zsolt Szegletes, Gaszton Vizsnyiczai, László Zimányi, Mária A. Deli, Szilvia Veszelka & Lóránd Kelemen. (2021) Optically Manipulated Microtools to Measure Adhesion of the Nanoparticle-Targeting Ligand Glutathione to Brain Endothelial Cells. ACS Applied Materials & Interfaces 13:33, pages 39018-39029.
Crossref
Mohamed HaddadVincent HervéMohamed Raâfet Ben KhedherJean-Michel RabanelCharles Ramassamy. (2021) Glutathione: An Old and Small Molecule with Great Functions and New Applications in the Brain and in Alzheimer's Disease. Antioxidants & Redox Signaling 35:4, pages 270-292.
Crossref
Dushko Shalabalija, Ljubica Mihailova, Maja Simonoska Crcarevska, Ivana Cvetkovikj Karanfilova, Vladimir Ivanovski, Aleksandra Kapedanovska Nestorovska, Gabriela Novotni & Marija Glavas Dodov. (2021) Formulation and optimization of bioinspired rosemary extract loaded PEGylated nanoliposomes for potential treatment of Alzheimer's disease using design of experiments. Journal of Drug Delivery Science and Technology 63, pages 102434.
Crossref
Laura Del Amo, Amanda Cano, Miren Ettcheto, Eliana B. Souto, Marta Espina, Antoni Camins, Maria Luísa García & Elena Sánchez-López. (2021) Surface Functionalization of PLGA Nanoparticles to Increase Transport across the BBB for Alzheimer’s Disease. Applied Sciences 11:9, pages 4305.
Crossref
Asim Najmi, Shenggang Wang, Yue Huang, Teresa Seefeldt, Yahya Alqahtani & Xiangming Guan. (2021) 2-(2-Cholesteroxyethoxyl)ethyl 3′-S-glutathionylpropionate and its self-assembled micelles for brain delivery: Design, synthesis and evaluation. International Journal of Pharmaceutics 600, pages 120520.
Crossref
Saurabh Mittal, Muhammad U. Ashhar, Farheen F. Qizilbash, Zufika Qamar, Jasjeet K. Narang, Shobhit Kumar, Javed Ali & Sanjula Baboota. (2020) Ligand Conjugated Targeted Nanotherapeutics for Treatment of Neurological Disorders. Current Pharmaceutical Design 26:19, pages 2291-2305.
Crossref
Basant Salah Mahmoud, Ali Hamod AlAmri & Christopher McConville. (2020) Polymeric Nanoparticles for the Treatment of Malignant Gliomas. Cancers 12:1, pages 175.
Crossref
Vijaykumar SutariyaShannon J. KellyRobert G. WeigelJared TurKathleen HalaszNirmal S. SharmaSrinivas M. Tipparaju. (2019) Nanoparticle drug delivery characterization for fluticasone propionate and in vitro testing. Canadian Journal of Physiology and Pharmacology 97:7, pages 675-684.
Crossref
Naveed Ullah Khan, Tongtong Miao, Xiufeng Ju, Qian Guo & Liang Han. 2019. Brain Targeted Drug Delivery System. Brain Targeted Drug Delivery System 129 158 .
Sunita Lahkar & Malay K. Das. 2019. Surface Modification of Nanoparticles for Targeted Drug Delivery. Surface Modification of Nanoparticles for Targeted Drug Delivery 277 310 .
Ranjana Bhandari, Jyoti K. Paliwal & Anurag Kuhad. (2018) Naringenin and its nanocarriers as potential phytotherapy for autism spectrum disorders. Journal of Functional Foods 47, pages 361-375.
Crossref
Caroline Gaucher, Ariane Boudier, Justine Bonetti, Igor Clarot, Pierre Leroy & Marianne Parent. (2018) Glutathione: Antioxidant Properties Dedicated to Nanotechnologies. Antioxidants 7:5, pages 62.
Crossref
Wang Ran & Xue Xue. (2018) Theranostical application of nanomedicine for treating central nervous system disorders. Science China Life Sciences 61:4, pages 392-399.
Crossref
Yuriy V. Loskutov, Caryn L. Griffin, Kristina M. Marinak, Andrey Bobko, Naira V. Margaryan, Werner J. Geldenhuys, Jann N. Sarkaria & Elena N. Pugacheva. (2018) LPA signaling is regulated through the primary cilium: a novel target in glioblastoma. Oncogene 37:11, pages 1457-1471.
Crossref
Jake Mazur, Kislay Roy & Jagat R Kanwar. (2018) Recent advances in nanomedicine and survivin targeting in brain cancers. Nanomedicine 13:1, pages 105-137.
Crossref
Ghislain Djiokeng Paka & Charles Ramassamy. (2016) Optimization of Curcumin-Loaded PEG-PLGA Nanoparticles by GSH Functionalization: Investigation of the Internalization Pathway in Neuronal Cells. Molecular Pharmaceutics 14:1, pages 93-106.
Crossref
Kuan-Hung Lin, Shu-Ting Hong, Hsiang-Tsui Wang, Yu-Li Lo, Anya Lin & James Yang. (2016) Enhancing Anticancer Effect of Gefitinib across the Blood–Brain Barrier Model Using Liposomes Modified with One α-Helical Cell-Penetrating Peptide or Glutathione and Tween 80. International Journal of Molecular Sciences 17:12, pages 1998.
Crossref
Alessandro Dalpiaz, Francesca Sacchetti, Anna Baldisserotto, Barbara Pavan, Eleonora Maretti, Valentina Iannuccelli & Eliana Leo. (2016) Application of the “in-oil nanoprecipitation” method in the encapsulation of hydrophilic drugs in PLGA nanoparticles. Journal of Drug Delivery Science and Technology 32, pages 283-290.
Crossref
R. S Acharya & R. V. P Reddy. (2015) GLUTATHIONE CONJUGATED PLGA NANOPARTICLES FOR ENHANCED BRAIN TARGETED DELIVERY OF A FLUORESCENT MARKER. INDIAN DRUGS 52:10, pages 23-33.
Crossref
A. Rizzo, C. Vasco, V. Girgenti, V. Fugnanesi, C. Calatozzolo, A. Canazza, A. Salmaggi, L. Rivoltini, M. Morbin & E. Ciusani. (2015) Melanoma Cells Homing to the Brain: An In Vitro Model . BioMed Research International 2015, pages 1-11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.